Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Barbara Haeberlin

Barbara Haeberlin, Munchenstein CH

Patent application numberDescriptionPublished
20080274189Organic Compounds Comprising a Glycopyrr Onium Salt - Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.11-06-2008
20080279948Treatment of Asthma and Copd Using Triple-Combination Therapy - A medicament comprising, separately or together (A) a compound of formula I11-13-2008
20080286363Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases - A medicament comprising, separately or together (A) a compound of formula I11-20-2008
20080317862Organic Compounds Comprising a Glycopyrrolium Salt - Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.12-25-2008
20100166671ORGANIC COMPOUNDS - Medicaments comprising (A) an antimuscarinic agent, (B) a beta-2 adrenoreceptor agonist and (C) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.07-01-2010
20100215734PHARMACEUTICAL COMPOSITIONS - The present invention provides a pharmaceutical composition in solid form comprising a poorly water soluble drug, a solubilizing component, and a surfactant which is semisolid or solid. The poorly soluble drug may e.g. be a cyclosporin or a macrolide.08-26-2010
20100221331PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - The present invention provides a pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide. The composition comprises 1 to 5% colloidal silicon dioxide by weight.09-02-2010

Patent applications by Barbara Haeberlin, Munchenstein CH

Barbara Haeberlin, M¨nchenstein CH

Patent application numberDescriptionPublished
20090209502COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION - A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.08-20-2009

Barbara Haeberlin, Kanton Baselland CH

Patent application numberDescriptionPublished
20110182830INHALATION DRUG PRODUCTS, SYSTEMS AND USES - Various embodiments of the present invention provide drug products, inhalation systems and methods of treating respiratory diseases. Several embodiments provide an inhalation system including a pressurized metered dose inhaler and a chamber. The chamber may be an anti-static chamber with a chamber volume of about 145 milliliters (ml) to about 200 ml.07-28-2011